aluates Reports

$ 0.0

Automative

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-9T7614

Global Acute Bacterial Skin And Skin Structure Infections ABSSSI Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-9T7614

Report

December 2024

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Furiex Pharmaceuticals, Inc.

GlaxoSmithKline PLC

Melinta Therapeutics Inc

Debiopharm International S.A.

MerLion Pharmaceuticals Pte Ltd

Durata Therapeutics, Inc.

Paratek Pharmaceuticals Inc.

Cempra Inc

Abbott Laboratories Inc

Actelion Pharmaceuticals Ltd

Albany Molecular Research Inc

Allergan plc

Astrazeneca plc

Bayer

Macrolide Pharmaceuticals, Inc.

Merck& Co. Inc

Pfizer Inc

Sanofi

Teva Pharmaceuticals Industries Ltd

Zavante Therapeutics Inc

Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market

According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic antibacterial therapy and patient hospitalization.

Market Analysis and Insights: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market

The global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Report

Report Metric	Details
Report Name	Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
CAGR	5%
Segment by Type	Delafloxacin Vancomycin Ceftaroline Fosamil Others
Segment by Application	Cellulitis Abscess Surgical Wounds Traumatic Wound
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Furiex Pharmaceuticals, Inc., GlaxoSmithKline plc, Melinta Therapeutics, Inc., Debiopharm International S.A., MerLion Pharmaceuticals Pte Ltd., Durata Therapeutics, Inc., Paratek Pharmaceuticals, Inc., Cempra, Inc., Abbott Laboratories, Inc., Actelion Pharmaceuticals Ltd., Albany Molecular Research, Inc., Allergan plc., AstraZeneca, Bayer AG, Macrolide Pharmaceuticals, Inc., Merck & Co, Inc., Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries Ltd., Zavante Therapeutics, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market report?

Ans: The main players in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market are Furiex Pharmaceuticals, Inc., GlaxoSmithKline plc, Melinta Therapeutics, Inc., Debiopharm International S.A., MerLion Pharmaceuticals Pte Ltd., Durata Therapeutics, Inc., Paratek Pharmaceuticals, Inc., Cempra, Inc., Abbott Laboratories, Inc., Actelion Pharmaceuticals Ltd., Albany Molecular Research, Inc., Allergan plc., AstraZeneca, Bayer AG, Macrolide Pharmaceuticals, Inc., Merck & Co, Inc., Pfizer, Inc., Sanofi, Teva Pharmaceuticals Industries Ltd., Zavante Therapeutics, Inc.

What are the Application segmentation covered in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market report?

Ans: The Applications covered in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market report are Cellulitis, Abscess, Surgical Wounds, Traumatic Wound

What are the Type segmentation covered in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market report?

Ans: The Types covered in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market report are Delafloxacin, Vancomycin, Ceftaroline Fosamil, Others

Recommended Reports

Skin Infection Treatments

Anti-Infective Drugs

Rare & Complex Conditions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Delafloxacin

1.2.3 Vancomycin

1.2.4 Ceftaroline Fosamil

1.2.5 Others

1.3 Market by Application

1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cellulitis

1.3.3 Abscess

1.3.4 Surgical Wounds

1.3.5 Traumatic Wound

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Perspective (2019-2030)

2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Region

2.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Dynamics

2.3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Trends

2.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers

2.3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges

2.3.4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Players

3.1.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2019-2024)

3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio

3.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2023

3.5 Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Head office and Area Served

3.6 Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Product and Application

3.7 Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Type

4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2025-2030)

5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Application

5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2019-2030)

6.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type

6.2.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024)

6.2.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030)

6.2.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

6.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

6.3.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024)

6.3.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030)

6.3.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

6.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country

6.4.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024)

6.4.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2019-2030)

7.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type

7.2.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024)

7.2.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030)

7.2.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

7.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

7.3.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024)

7.3.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030)

7.3.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

7.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country

7.4.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024)

7.4.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2019-2030)

8.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type

8.2.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024)

8.2.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030)

8.2.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

8.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

8.3.1 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024)

8.3.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030)

8.3.3 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2019-2030)

9.2 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type

9.2.1 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024)

9.2.2 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030)

9.2.3 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

9.3 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

9.3.1 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024)

9.3.2 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030)

9.3.3 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

9.4 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region

9.4.1 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2019-2024)

9.4.3 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Furiex Pharmaceuticals, Inc.

11.1.1 Furiex Pharmaceuticals, Inc. Company Details

11.1.2 Furiex Pharmaceuticals, Inc. Business Overview

11.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.1.5 Furiex Pharmaceuticals, Inc. Recent Developments

11.2 GlaxoSmithKline plc

11.2.1 GlaxoSmithKline plc Company Details

11.2.2 GlaxoSmithKline plc Business Overview

11.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.2.5 GlaxoSmithKline plc Recent Developments

11.3 Melinta Therapeutics, Inc.

11.3.1 Melinta Therapeutics, Inc. Company Details

11.3.2 Melinta Therapeutics, Inc. Business Overview

11.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.3.5 Melinta Therapeutics, Inc. Recent Developments

11.4 Debiopharm International S.A.

11.4.1 Debiopharm International S.A. Company Details

11.4.2 Debiopharm International S.A. Business Overview

11.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.4.5 Debiopharm International S.A. Recent Developments

11.5 MerLion Pharmaceuticals Pte Ltd.

11.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details

11.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview

11.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Developments

11.6 Durata Therapeutics, Inc.

11.6.1 Durata Therapeutics, Inc. Company Details

11.6.2 Durata Therapeutics, Inc. Business Overview

11.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.6.5 Durata Therapeutics, Inc. Recent Developments

11.7 Paratek Pharmaceuticals, Inc.

11.7.1 Paratek Pharmaceuticals, Inc. Company Details

11.7.2 Paratek Pharmaceuticals, Inc. Business Overview

11.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.7.5 Paratek Pharmaceuticals, Inc. Recent Developments

11.8 Cempra, Inc.

11.8.1 Cempra, Inc. Company Details

11.8.2 Cempra, Inc. Business Overview

11.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.8.5 Cempra, Inc. Recent Developments

11.9 Abbott Laboratories, Inc.

11.9.1 Abbott Laboratories, Inc. Company Details

11.9.2 Abbott Laboratories, Inc. Business Overview

11.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.9.5 Abbott Laboratories, Inc. Recent Developments

11.10 Actelion Pharmaceuticals Ltd.

11.10.1 Actelion Pharmaceuticals Ltd. Company Details

11.10.2 Actelion Pharmaceuticals Ltd. Business Overview

11.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.10.5 Actelion Pharmaceuticals Ltd. Recent Developments

11.11 Albany Molecular Research, Inc.

11.11.1 Albany Molecular Research, Inc. Company Details

11.11.2 Albany Molecular Research, Inc. Business Overview

11.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.11.5 Albany Molecular Research, Inc. Recent Developments

11.12 Allergan plc.

11.12.1 Allergan plc. Company Details

11.12.2 Allergan plc. Business Overview

11.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.12.5 Allergan plc. Recent Developments

11.13 AstraZeneca

11.13.1 AstraZeneca Company Details

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.13.5 AstraZeneca Recent Developments

11.14 Bayer AG

11.14.1 Bayer AG Company Details

11.14.2 Bayer AG Business Overview

11.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.14.5 Bayer AG Recent Developments

11.15 Macrolide Pharmaceuticals, Inc.

11.15.1 Macrolide Pharmaceuticals, Inc. Company Details

11.15.2 Macrolide Pharmaceuticals, Inc. Business Overview

11.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.15.5 Macrolide Pharmaceuticals, Inc. Recent Developments

11.16 Merck & Co, Inc.

11.16.1 Merck & Co, Inc. Company Details

11.16.2 Merck & Co, Inc. Business Overview

11.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.16.5 Merck & Co, Inc. Recent Developments

11.17 Pfizer, Inc.

11.17.1 Pfizer, Inc. Company Details

11.17.2 Pfizer, Inc. Business Overview

11.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.17.5 Pfizer, Inc. Recent Developments

11.18 Sanofi

11.18.1 Sanofi Company Details

11.18.2 Sanofi Business Overview

11.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.18.5 Sanofi Recent Developments

11.19 Teva Pharmaceuticals Industries Ltd.

11.19.1 Teva Pharmaceuticals Industries Ltd. Company Details

11.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview

11.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.19.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.19.5 Teva Pharmaceuticals Industries Ltd. Recent Developments

11.20 Zavante Therapeutics, Inc.

11.20.1 Zavante Therapeutics, Inc. Company Details

11.20.2 Zavante Therapeutics, Inc. Business Overview

11.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction

11.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

11.20.5 Zavante Therapeutics, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Furiex Pharmaceuticals, Inc.

GlaxoSmithKline PLC

Melinta Therapeutics Inc

Debiopharm International S.A.

MerLion Pharmaceuticals Pte Ltd

Durata Therapeutics, Inc.

Paratek Pharmaceuticals Inc.

Cempra Inc

Abbott Laboratories Inc

Actelion Pharmaceuticals Ltd

Albany Molecular Research Inc

Allergan plc

Astrazeneca plc

Bayer

Macrolide Pharmaceuticals, Inc.

Merck& Co. Inc

Pfizer Inc

Sanofi

Teva Pharmaceuticals Industries Ltd

Zavante Therapeutics Inc

List of Tables

Table 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Delafloxacin

Table 3. Key Players of Vancomycin

Table 4. Key Players of Ceftaroline Fosamil

Table 5. Key Players of Others

Table 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2019-2024)

Table 10. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2025-2030)

Table 12. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Trends

Table 13. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers

Table 14. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges

Table 15. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints

Table 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2023)

Table 19. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Product and Application

Table 23. Global Key Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Application (2019-2024)

Table 31. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Application (2025-2030)

Table 33. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. Furiex Pharmaceuticals, Inc. Company Details

Table 66. Furiex Pharmaceuticals, Inc. Business Overview

Table 67. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 68. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 69. Furiex Pharmaceuticals, Inc. Recent Developments

Table 70. GlaxoSmithKline plc Company Details

Table 71. GlaxoSmithKline plc Business Overview

Table 72. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 73. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 74. GlaxoSmithKline plc Recent Developments

Table 75. Melinta Therapeutics, Inc. Company Details

Table 76. Melinta Therapeutics, Inc. Business Overview

Table 77. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 78. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 79. Melinta Therapeutics, Inc. Recent Developments

Table 80. Debiopharm International S.A. Company Details

Table 81. Debiopharm International S.A. Business Overview

Table 82. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 83. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 84. Debiopharm International S.A. Recent Developments

Table 85. MerLion Pharmaceuticals Pte Ltd. Company Details

Table 86. MerLion Pharmaceuticals Pte Ltd. Business Overview

Table 87. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 88. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 89. MerLion Pharmaceuticals Pte Ltd. Recent Developments

Table 90. Durata Therapeutics, Inc. Company Details

Table 91. Durata Therapeutics, Inc. Business Overview

Table 92. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 93. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 94. Durata Therapeutics, Inc. Recent Developments

Table 95. Paratek Pharmaceuticals, Inc. Company Details

Table 96. Paratek Pharmaceuticals, Inc. Business Overview

Table 97. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 98. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 99. Paratek Pharmaceuticals, Inc. Recent Developments

Table 100. Cempra, Inc. Company Details

Table 101. Cempra, Inc. Business Overview

Table 102. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 103. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 104. Cempra, Inc. Recent Developments

Table 105. Abbott Laboratories, Inc. Company Details

Table 106. Abbott Laboratories, Inc. Business Overview

Table 107. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 108. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 109. Abbott Laboratories, Inc. Recent Developments

Table 110. Actelion Pharmaceuticals Ltd. Company Details

Table 111. Actelion Pharmaceuticals Ltd. Business Overview

Table 112. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 113. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 114. Actelion Pharmaceuticals Ltd. Recent Developments

Table 115. Albany Molecular Research, Inc. Company Details

Table 116. Albany Molecular Research, Inc. Business Overview

Table 117. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 118. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 119. Albany Molecular Research, Inc. Recent Developments

Table 120. Allergan plc. Company Details

Table 121. Allergan plc. Business Overview

Table 122. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 123. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 124. Allergan plc. Recent Developments

Table 125. AstraZeneca Company Details

Table 126. AstraZeneca Business Overview

Table 127. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 128. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 129. AstraZeneca Recent Developments

Table 130. Bayer AG Company Details

Table 131. Bayer AG Business Overview

Table 132. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 133. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 134. Bayer AG Recent Developments

Table 135. Macrolide Pharmaceuticals, Inc. Company Details

Table 136. Macrolide Pharmaceuticals, Inc. Business Overview

Table 137. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 138. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 139. Macrolide Pharmaceuticals, Inc. Recent Developments

Table 140. Merck & Co, Inc. Company Details

Table 141. Merck & Co, Inc. Business Overview

Table 142. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 143. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 144. Merck & Co, Inc. Recent Developments

Table 145. Pfizer, Inc. Company Details

Table 146. Pfizer, Inc. Business Overview

Table 147. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 148. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 149. Pfizer, Inc. Recent Developments

Table 150. Sanofi Company Details

Table 151. Sanofi Business Overview

Table 152. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 153. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 154. Sanofi Recent Developments

Table 155. Teva Pharmaceuticals Industries Ltd. Company Details

Table 156. Teva Pharmaceuticals Industries Ltd. Business Overview

Table 157. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 158. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 159. Teva Pharmaceuticals Industries Ltd. Recent Developments

Table 160. Zavante Therapeutics, Inc. Company Details

Table 161. Zavante Therapeutics, Inc. Business Overview

Table 162. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product

Table 163. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024) & (US$ Million)

Table 164. Zavante Therapeutics, Inc. Recent Developments

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type: 2023 VS 2030

Figure 3. Delafloxacin Features

Figure 4. Vancomycin Features

Figure 5. Ceftaroline Fosamil Features

Figure 6. Others Features

Figure 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2023 VS 2030

Figure 9. Cellulitis Case Studies

Figure 10. Abscess Case Studies

Figure 11. Surgical Wounds Case Studies

Figure 12. Traumatic Wound Case Studies

Figure 13. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered

Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players in 2023

Figure 18. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2023

Figure 20. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

Figure 22. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

Figure 23. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2019-2030)

Figure 24. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

Figure 28. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

Figure 29. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2019-2030)

Figure 30. Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

Figure 38. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

Figure 39. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

Figure 41. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

Figure 42. Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2019-2030)

Figure 43. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 60. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 61. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 62. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 63. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 64. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 65. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 66. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 67. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 68. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 69. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 70. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 71. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 72. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 73. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 74. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 75. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 76. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 77. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 78. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2019-2024)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350